Commentary: Resonance-induced Therapeutic Technique for Skin Cancer Cells
Loading...
Files
Size: 2.28 MB, File format: Adobe PDF
Date
Authors
Al-Jumaily, Ahmed
Liaquat, Hassan
Supervisor
Item type
Degree name
Journal Title
Journal ISSN
Volume Title
Publisher
Sciaccess Publishers LLC
Abstract
[From Introduction] Basal cell carcinoma (BCC) has the highest occurrence among Non-Melanoma Skin Cancers (NMSC), representing a substantial clinical and economic burden, particularly in regions such as the Southern Hemisphere, where annual treatment costs alone are projected to reach USD 950 million1. An estimated 90,000 non-melanoma and 7000 melanoma skin cancers are diagnosed each year in New Zealand alone, resulting in almost 500 deaths per year2, 3. It poses persistent treatment challenges due to its potential for local invasion and recurrence. Current treatment techniques are either invasive, such as surgery, or they are non-invasive, like gamma radiation, with significant side effects, which include thermal ablation, long recovery periods, and even a breeding ground for second cancer4.
Description
Keywords
Resonance-Induced Therapeutic Technique, Skin Cancer Cells, Basal cell carcinoma (BCC), Non-Melanoma Skin Cancers (NMSC)
Source
Journal of Dermatology and Skin Science, ISSN: 2767-5092 (Print); 2767-5092 (Online), Sciaccess Publishers LLC, 8(1), 6-9. doi: 10.29245/2767-5092/2026/1.1201
Rights statement
© 2026 Al-Jumaily AM. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.
Permanent link
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Creative Commons Attribution License